v3.26.1
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Sep. 11, 2024
Jun. 17, 2024
Mar. 11, 2024
Nov. 03, 2023
Jul. 27, 2023
Jul. 05, 2023
Jan. 31, 2023
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Loss Contingencies [Line Items]                    
Upfront payment             $ 150,000      
Future payment upon meeting milestone             $ 1,000,000      
Value of common stock issued               $ 34,993,414    
Payments for research and development     $ 50,000              
Maximum [Member]                    
Loss Contingencies [Line Items]                    
Payment of milestone amount       $ 27,250,000            
Minotaur Agreement [Member]                    
Loss Contingencies [Line Items]                    
License fees               0 $ 0  
ABSI [Member]                    
Loss Contingencies [Line Items]                    
Common stock issued         25,107          
Value of common stock issued         $ 250,000          
Payments for research and development               0 50,000  
ABSI [Member] | Maximum [Member]                    
Loss Contingencies [Line Items]                    
ABSI shares issued, shares           $ 8,250,000        
ABSI [Member]                    
Loss Contingencies [Line Items]                    
Net proceeds from offering           $ 10,000,000        
Intract Patent License Agreement (Member)                    
Loss Contingencies [Line Items]                    
Upfront payment $ 400,000     400,000            
License fees               0 600,000  
Milestone fees       $ 150,000           $ 150,000
Avior Patent License Agreement [Member]                    
Loss Contingencies [Line Items]                    
Milestone fees               0 200,000  
Enkefalos License Agreement [Member]                    
Loss Contingencies [Line Items]                    
Upfront payment   $ 150,000                
License fees               $ 0 $ 200,000